Medicine guide
Nemluvio
30 mg/100mg · Injection, Powder, Lyophilized, for Solution
- Prescription only
- Interleukin-31 Receptor alpha Antagonist
- Active substance
- Nemolizumab-Ilto
- Made by
- Galderma Laboratories, L.P.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicines
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Galderma Laboratories, L.P. |
|---|---|
| Active substance | Nemolizumab-Ilto |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 30 mg/100mg |
| Form | Injection, Powder, Lyophilized, for Solution |
| Route | Subcutaneous |
| Packs | 1 SYRINGE, GLASS in 1 CARTON / 30 mg in 1 SYRINGE, GLASS · 1 SYRINGE in 1 CARTON / 30 mg in 1 SYRINGE |
| NDC | 0299-6220 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).